ND

Nick Damiano

Surgical robots + AI | CEO & Co-Founder @ Andromeda Surgical | YC S23 & W15

San Francisco, California

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • CEO & Co-Founder

    2023

    Autonomous surgical robots with initial focus on urology YC S23

  • Venture Partner

    2017

    Y Combinator alumni venture fund Most active seed investor in the world as per Pitchbook

2014 - 2023

  • Founder & Advisor

    2022 - 2023

  • CEO & Founder

    2014 - 2022

    Co-invented novel minimally invasive treatment for urinary obstruction related to BPH (enlarged prostate) Led company from concept through large randomized studies & market readiness Product has successfully treated > 300 patients in six countries Raised > $60M in venture, angel, debt, and grant funding Hired and led elite team of 28 FTEs First medtech company funded by Y Combinator (YC W15)

2022 - 2023

  • Chief Strategy Officer

    2022 - 2023

    A new & more powerful adult pluripotent stem cell platform for difficult-to-treat diseases

  • Co-Founder & Advisor

    2014 - 2018

    Company was acquired by Mendaera Formerly known as Nurep

  • Co-Founder & CTO

    2012 - 2014

    Initially known as Nurep, Inc. Mobile platform to help medical device companies remotely support surgical cases Built initial commercially launched product and closed first sale Company has raised > $100M in venture funding and launched in ~1000 hospitals

2014 - 2014

  • Biodesign Fellow Externship

    2014 - 2014

    Advised India-based medtech company on global commercialization strategy

  • Biodesign Innovation Fellow

    2013 - 2014

    Each year an international search brings a group of fellows to Biodesign with the talent and skillset to spark the creative process and innovate.

2013 - 2013

  • Entrepreneur

    2013 - 2013

    Blueprint Health is a Charter Member of the Global Accelerator Network, which was started by TechStars

2008 - 2012

  • Research Engineer

    2008 - 2012

    Developed key algorithms for world's first fully functional leadless pacemaker ASX: EBR